Co-Diagnostics, Inc. Reveals Pricing for $3.8 Million Registered Direct Offering of Common Stock at Market Rate According to Nasdaq Regulations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 17 2025
0mins
Source: Newsfilter
Securities Offering Announcement: Co-Diagnostics, Inc. has entered into a securities purchase agreement to sell 9,619,000 shares of common stock at $0.40 per share, aiming to raise approximately $3.8 million for working capital and corporate purposes.
Regulatory Compliance: The offering is conducted under a shelf registration statement effective since April 2023, with the closing expected on September 18, 2025, pending customary conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
